Accurate tuberculosis detection in immunosuppressed patients requires specialized diagnostic approaches. The Medical Centre for Infectious Diseases Berlin has implemented T-SPOT.TB testing with automated ELISPOT workflows to address the unique challenges of TB screening in immunocompromised populations. This case study demonstrates how combining reliable interferon-gamma release assay technology with streamlined laboratory automation improves diagnostic accuracy while enhancing workflow efficiency.

In this case study you will learn:

• How T-SPOT.TB with automated processing delivers reliable TB detection in immunosuppressed patients
• Why automated ELISPOT workflows improve laboratory efficiency while maintaining diagnostic precision for high-risk populations
• The clinical impact of combining advanced TB testing technology with streamlined automation in real-world laboratory settings

"With tools like T-SPOT.TB and new automation technologies, we are better equipped to identify and manage TB infections in even the most vulnerable patients." 

- Dr. Martin Obermeier, Medical Centre for Infectious Diseases Berlin

Complete the form below to access the full case study and discover more on Dr Obermeier’s experience with the T-SPOT.TB test.
 

For in vitro diagnostic use. This product is only available where licensed in accordance with law. Please contact your local representative for availability.

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.